Published in Schizophr Bull on June 28, 2016
Editorial: Third-Generation Neuroimaging: Translating Research into Clinical Utility. Front Psychiatry (2016) 0.75
Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage (1999) 40.38
Complex brain networks: graph theoretical analysis of structural and functional systems. Nat Rev Neurosci (2009) 27.56
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage (2006) 25.52
Complex network measures of brain connectivity: uses and interpretations. Neuroimage (2009) 20.48
Dissociable intrinsic connectivity networks for salience processing and executive control. J Neurosci (2007) 19.58
Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry (2005) 6.27
Small-world anatomical networks in the human brain revealed by cortical thickness from MRI. Cereb Cortex (2007) 5.89
Hierarchical organization of human cortical networks in health and schizophrenia. J Neurosci (2008) 5.19
Rethinking schizophrenia. Nature (2010) 4.85
Functional connectivity and brain networks in schizophrenia. J Neurosci (2010) 4.81
Whole-brain anatomical networks: does the choice of nodes matter? Neuroimage (2009) 4.43
Aberrant frontal and temporal complex network structure in schizophrenia: a graph theoretical analysis. J Neurosci (2010) 3.80
BrainNet Viewer: a network visualization tool for human brain connectomics. PLoS One (2013) 3.74
Schizophrenia, neuroimaging and connectomics. Neuroimage (2012) 2.49
Abnormal rich club organization and functional brain dynamics in schizophrenia. JAMA Psychiatry (2013) 2.47
Small-world networks and disturbed functional connectivity in schizophrenia. Schizophr Res (2006) 2.15
A surface-based approach to quantify local cortical gyrification. IEEE Trans Med Imaging (2008) 2.14
Does the salience network play a cardinal role in psychosis? An emerging hypothesis of insular dysfunction. J Psychiatry Neurosci (2012) 1.88
Altered resting state complexity in schizophrenia. Neuroimage (2011) 1.81
Graph analysis of the human connectome: promise, progress, and pitfalls. Neuroimage (2013) 1.80
Imaging structural co-variance between human brain regions. Nat Rev Neurosci (2013) 1.65
Network-level structural covariance in the developing brain. Proc Natl Acad Sci U S A (2010) 1.60
A neurodevelopmental approach to the classification of schizophrenia. Schizophr Bull (1992) 1.56
Patterns of coordinated anatomical change in human cortical development: a longitudinal neuroimaging study of maturational coupling. Neuron (2011) 1.52
Neural primacy of the salience processing system in schizophrenia. Neuron (2013) 1.50
Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment. Am J Psychiatry (2015) 1.49
Prefrontal sulcal prominence is inversely related to response to clozapine in schizophrenia. Biol Psychiatry (1991) 1.48
Local gyrification index in probands with psychotic disorders and their first-degree relatives. Biol Psychiatry (2013) 1.45
Structural connectomics in brain diseases. Neuroimage (2013) 1.38
GAT: a graph-theoretical analysis toolbox for analyzing between-group differences in large-scale structural and functional brain networks. PLoS One (2012) 1.31
Networks of anatomical covariance. Neuroimage (2013) 1.29
The convergence of maturational change and structural covariance in human cortical networks. J Neurosci (2013) 1.26
Developmental changes in organization of structural brain networks. Cereb Cortex (2012) 1.21
Cortical folding abnormalities in schizophrenia patients with resistant auditory hallucinations. Neuroimage (2007) 1.20
Anatomical insights into disrupted small-world networks in schizophrenia. Neuroimage (2011) 1.19
White matter integrity as a predictor of response to treatment in first episode psychosis. Brain (2013) 1.16
Aberrant cortical gyrification in schizophrenia: a surface-based morphometry study. J Psychiatry Neurosci (2012) 1.15
Remission in early psychosis: Rates, predictors, and clinical and functional outcome correlates. Schizophr Res (2006) 1.09
Cortical folding defects as markers of poor treatment response in first-episode psychosis. JAMA Psychiatry (2013) 1.08
Morphological consequences of prenatal injury to the primate brain. Prog Brain Res (1980) 1.07
Gyrification and neural connectivity in schizophrenia. Dev Psychopathol (2011) 1.06
Anomalous gray matter structural networks in major depressive disorder. Biol Psychiatry (2013) 1.06
Very poor outcome schizophrenia: clinical and neuroimaging aspects. Int Rev Psychiatry (2007) 1.04
Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance. Am J Psychiatry (1997) 1.02
Abnormal topological organization of structural brain networks in schizophrenia. Schizophr Res (2012) 1.01
Increased prefrontal gyrification in a large high-risk cohort characterizes those who develop schizophrenia and reflects abnormal prefrontal development. Biol Psychiatry (2007) 0.96
Diagnostic discontinuity in psychosis: a combined study of cortical gyrification and functional connectivity. Schizophr Bull (2013) 0.93
Antipsychotic Drugs Alter Functional Connectivity between the Medial Frontal Cortex, Hippocampus, and Nucleus Accumbens as Measured by H215O PET. Front Psychiatry (2012) 0.89
Cortex morphology in first-episode psychosis patients with neurological soft signs. Schizophr Bull (2012) 0.87
Brain connectivity and gyrification as endophenotypes for schizophrenia: weight of the evidence. Curr Top Med Chem (2012) 0.86
Obstetric complications predict treatment response in first-episode schizophrenia. Psychol Med (1999) 0.82
Anatomical coupling among distributed cortical regions in youth varies as a function of individual differences in vocabulary abilities. Hum Brain Mapp (2013) 0.82
Neurological soft signs and their relationship to cognitive and clinical efficacy of atypical antipsychotics in schizophrenia. Schizophr Bull (2004) 0.80
Clozapine may partially compensate for task-related brain perfusion abnormalities in risperidone-resistant schizophrenia patients. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.79
Brain changes in Alzheimer's disease patients with implanted encapsulated cells releasing nerve growth factor. J Alzheimers Dis (2015) 0.80
Genetic moderation of the effects of cannabis: Catechol-O-methyltransferase (COMT) affects the impact of Δ9-tetrahydrocannabinol (THC) on working memory performance but not on the occurrence of psychotic experiences. J Psychopharmacol (2015) 0.76